Defective Interfering Particles of Influenza Virus and Their Characteristics, Impacts, and Use in Vaccines and Antiviral Strategies: A Systematic Review.

Wu, Min; Zhou, Entong; Sheng, Rui; Fu, Xiaoshu; Li, Jiemin; Jiang, Chunlai; Su, Weiheng

Wu, Min; Zhou, Entong; Sheng, Rui; Fu, Xiaoshu; Li, Jiemin; Jiang, Chunlai; Su, Weiheng.

Afiliação

Wu M; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.
Zhou E; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.
Sheng R; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.
Fu X; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.
Li J; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.
Jiang C; National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China.
Su W; Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, School of Life Sciences, Jilin University, Changchun 130012, China.

Viruses ; 14(12)2022 12 12.

Article em En | MEDLINE | ID: mdl-36560777

Assuntos

COVID-19; Vacinas contra Influenza; Orthomyxoviridae; Humanos; Antivirais; Vírus Defeituosos Interferentes; Vírus Defeituosos/fisiologia; SARS-CoV-2; Orthomyxoviridae/genética; Replicação Viral/genética

Palavras-chave

NS1; antiviral; clinical trial; defective interfering particles; defective viral genomes; influenza virus; interferon; live attenuated influenza vaccine; viral replication

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Orthomyxoviridae / Vacinas contra Influenza / COVID-19 Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google